Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $177.6000 (-3.7%) ($176.8500 - $184.5000) on Tue. Jul. 21, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.68% (three month average) | RSI | 62 | Latest Price | $177.6000(-3.7%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 2.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) XLC(26%) IYT(17%) BOTZ(11%) VFMO(10%) ACES(9%) | Factors Impacting SGEN price | SGEN will decline at least -1.34% in a week (0% probabilities). UUP(-7%) TBT(-3%) DRIV(-3%) XOP(-2%) XLE(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.34% (StdDev 2.68%) | Hourly BBV | 0 () | Intraday Trend | -3.7% | | | |
|
5 Day Moving Average | $180.89(-1.82%) | 10 Day Moving Average | $178.13(-0.3%) | 20 Day Moving Average | $173.89(2.13%) | To recent high | -3.7% | To recent low | 29.4% | Market Cap | $30.878b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |